Treatment of Non-erosive Effect of Clinical Study of Gastroesophageal Reflux Disease
Abstract
Abstract: Objective: To observe the clinical effect of “Chaihu Shugan Powder Zuojin Pill†in the treatment of non-erosive gastroesophageal reflux disease. Methods: Sixty patients with non-erosive gastroesophageal reflux disease were randomly divided into treatment group and control group (30 cases in each group). The patients were treated with “Zaohu Shugan Powder†and “Zangjin Pills†and omeprazole respectively. For 8 weeks, the clinical efficacy and changes in clinical symptoms were observed. Results: The total effective rate was 93.3% in the treatment group and 80.0% in the control group. There was significant difference between the two groups before and after treatment (P <0.05). Conclusion: “Chaihu Shugan Powder Zuojin Pill†can effectively improve the clinical symptoms of non-erosive gastroesophageal reflux disease.
References
2.SanRen Lin, GuoMing Xu, PinJin Hu, et al. Chinese gastroesophageal reflux disease consensus opinion [J]. Gastroenterology, 2007, 12 (4): 233-299.
3.XiaoYu Zheng. Traditional Chinese medicine clinical research guidelines [M]. Beijing: China Medical Science and Technology Press, 2002: 215-220.
4.ShengLiang Zhu, YongShun Sun, ShuPing Ma. Gastroesophageal reflux disease traditional Chinese medicine syndrome analysis [J]. Shanghai Journal of Traditional Chinese Medicine, 2006,40 (10): 28-29.
5.QianZheng Li. Traditional Chinese medicine of gastroenterology [M]. Beijing: China Medical Science and Technology Press, 1993: 446.
FuQiang Ye, WeeWen Chen. Pharmacological research of “ZuoJinWan†[J]. Chinese Patent Medicine. 1998, 18 (1): 43.
Copyright (c) 2017 Qian Liu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.